COMP <GO>
GUTS vs CNSY // FREE CASH FLOW YIELD
Fractyl Health Inc. (NASDAQ) VS. Cerenome Inc. (NASDAQ) • 15-METRIC TALLY: GUTS 0
— CNSY 2
■ METRIC PARITY
LAST: $0.99 (+11.40%) • MKT CAP: $13.2M
fcf-yield
—
LAST: $1.74 (0.00%) • MKT CAP: $13.2M
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GUTS VS. CNSY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GUTS | CNSY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -10.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 17.0 | 43.2 | -26.20 | CNSY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.2M | $13.2M | -$53.7K | CNSY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GUTS REV | CNSY REV | GUTS GROSS % | CNSY GROSS % | GUTS FCF | CNSY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $5.2M | — | — | -$90.9M | -$20.8M |
| FY 2024 | $93.0K | $5.8M | 46.2% | — | -$67.3M | -$10.7M |
| FY 2023 | $0 | $4.9M | — | — | -$42.8M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GUTS // BETA —
CNSY // BETA —